This case underscores that life-threatening ketoacidosis can develop despite near-normal glucose and prior tolerance of acute illness and highlights the importance of early recognition, standardized treatment, and “sick day” precautions for patients taking SGLT2 inhibitors. Here, SLC5A2 is linked to type 2 diabetes mellitus.